Enter assignee name

EPO Patents = 5

Trademarks = 5

Forward Citations = 24

Loading Chart...

14 inventors (with patents filed for the assignee):

Elai Davicioni (7 out of 15 patents)

Nicholas Erho (6 out of 7 patents)

Hussam Al-Deen Ashab (3 out of 3 patents)

4. Shuang Zhao (2 out of 5 patents)

5. Ismael A Vergara Correa (2 out of 3 patents)

6. Felix Y Feng (2 out of 3 patents)

7. Sei-Won Laura Chang (1 out of 1 patent)

8. Peter Black (1 out of 1 patent)

9. Mohammed Alshalalfa (1 out of 1 patent)

10. Christine Buerki (1 out of 2 patents)

11. Anamaria Crisan (1 out of 2 patents)

12. Mercedeh Ghadessi (1 out of 2 patents)

13. Robert B Jenkins (1 out of 18 patents)

14. S Laura Chang (1 out of 1 patent)

15. Nicholas George Erho (2 patents)

7 patents: Sort by Forward Citations

1. 11873532 - Subtyping prostate cancer to predict response to hormone therapy (2024-01-16),

2. 11414708 - Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy (2022-08-16),

3. 11208697 - Molecular subtyping, prognosis, and treatment of bladder cancer (2021-12-28),

4. 11078542 - Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness (2021-08-03),

5. 11035005 - Cancer diagnostics using biomarkers (2021-06-15),

6. 10865452 - Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer (2020-12-15),

7. 10513737 - Cancer diagnostics using non-coding transcripts (2019-12-24),

Decipher Biosciences is a precision oncology company focused on developing and delivering advanced cancer diagnostics that provide actionable information to healthcare providers and patients. The company's innovative technology platform integrates genomic data with clinical information to guide personalized treatment decisions for cancer patients.

This text is generated by artificial intelligence and may not be accurate.